Experts from the WMD Center offer insights and opinions related to COVID-19.
INSS Strategic Insights | Aug. 18, 2021
Diane DiEuliis & Patrick Terrell
Many have acknowledged that the COVID19 pandemic was not a failure of our imagination – we’ve been preparing for such an event for decades by building biotechnologies for biosurveillance and medicines, conducting exercises, and stockpiling of medical supplies. Response to a spreading illness in many ways is not rocket science: treat the sick, protect the vulnerable, and stop the spread – mainly accomplished via the tools and products of biotechnology. Many are now asking, what could we have done better in the pandemic response?
READ MORE →
War on the Rocks | June 7, 2021
Amanda Moodie and Nicholas Evans
In a recent article in War on the Rocks, Ms. Amanda Moodie and Dr. Nicholas Evans explore how U.S. policy priorities should focus on both identifying and preventing the spread of zoonotic pathogens and bolstering safety and security in high-containment laboratories.
Inkstick | April 7, 2021
Sarah Jacobs Gamberini
In the second article in Inkstick's series on The Future of National Security Work, CSWMD's Sarah Jacobs Gamberini pens a personal essay on the unexpected benefits of pandemic telework as a working mom in the defense world.
Strategic Insights | March 11, 2021
Peter Emanuel Ph.D., Brian Feeney Ph.D. and Diane DiEuliis Ph.D.
U.S. industry’s distribution system and supply chains were vulnerable before COVID, but pandemic-related disruptions to supply chains fully exposed this already alarming problem. U.S. manufacturers have relied too heavily on foreign materials for production, and the steady off-shoring of critical industries over a course of decades has reduced direct control of vital defense-related manufacturing should it be needed.
OxPol: The Oxford University Politics Blog | June 24, 2020
Nima Gerami and Amanda Moodie
While Covid-19 has spurred debate about the need to elevate public health as a security concern, the securitisation of health presents both opportunities and trade-offs that need to be considered if we are to reallocate military spending to prepare for the next pandemic. Mr. Nima Gerami and Ms. Amanda Moodie address these issues in their latest for The Oxford University Politics Blog.
Inkstick | May 7, 2020
Sarah Jacobs Gamberini and Amanda Moodie
In their article in Inkstick, Ms. Sarah Jacobs Gamberini and Ms. Amanda Moodie examine China's authoritarian approach to COVID-19 in the context of great power competition.
Strategic Insights | April 27, 2020
Diane DiEuliis, Peter Emanuel, Alexander Titus, and James Giordano
The current pandemic gives us an opportunity to envision new tools, methods, and response policies that leverage emerging technologies, which, if adopted and prudently employed, would enable capability to far better predict, prepare, if not prevent the “next” biosecurity war, and not merely repeat the errors of the “last”.
Strategic Insights | April 13, 2020
Diane DiEuliis and Laura Junor
In the latest Institute for National Strategic Studies "Strategic Insight," Dr. Diane DiEuliis and Dr. Laura Junor examine what the Department of Defense needs to maintain force readiness during the coronavirus (COVID-19) pandemic. Force readiness and management will be improved by rapidly deploying a point of care serological test to all in the U.S. military.
War on the Rocks | April 6, 2020
In their latest for War on the Rocks, Ms. Sarah Jacobs Gamberini and Ms. Amanda Moodie examine the similarities between current Covid-19 related disinformation campaigns and biological influence operations conducted during the Cold War.
Medium | April 2, 2020
Alexander Titus, Michelle Rozo, and Diane DiEuliis
Alexander Titus, Michelle Rozo, and Diane DiEuliis provide some perspective on the importance of using advanced biotechnology capabilities during the global pandemic.
Inkstick | March 25, 2020
Justin Anderson and Sarah Jacobs Gamberini
In their article in Inkstick, Dr. Justin Anderson and Ms. Sarah Jacobs Gamberini examine the daunting challenge of attempting to halt the spread of misinformation (erroneous information) and disinformation (deliberately false information) about the coronavirus (COVID-19).